東山精密(002384.SZ):擬開展商品期貨套期保值業務
格隆匯6月14日丨東山精密(002384.SZ)公佈,公司2021年6月11日召開第五屆董事會第十二次會議,審議通過了《關於開展商品期貨套期保值業務的議案》,同意公司及子公司開展商品期貨套期保值業務,商品期貨套期保值業務佔用的可循環使用的保證金最高額度不超過公司2020年度經審計淨資產的5%,上述交易額度在董事會審議通過之日起12個月內可滾動使用,並授權管理層在額度範圍內根據公司的《商品期貨套期保值業務管理制度》(2021年6月修訂)具體實施上述商品期貨套期保值業務相關事宜。
根據《深圳證券交易所股票上市規則》和《公司章程》等相關規定,該交易事項無需提交股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.